Ocular Surface Disease Delaying Cataract Surgery Decisions
Unstable ocular surface disease can reduce the accuracy of presurgical IOL measurements and affect intraocular lens power calculations, Ophthalmology Times reported. Preserving refractive precision requires identifying subtypes of ocular surface disease that alter astigmatism magnitude and axis. These conditions also increase postoperative infection risks, particularly endophthalmitis, when pathogens like gram-positive bacteria are present in Demodex blepharitis.
Surgeons must also account for disease progression after procedures, especially when patients receive multifocal or extended-depth-of-focus lenses. Dry eye disease frequently flares after cataract surgery. If a condition sits at a nonvisually significant stage beforehand, it can become visually significant during recovery. Clinics must discuss this trajectory with patients, provide prophylactic treatment, and scale up therapies postsurgically.
Screening Protocols Across Busy Surgical Clinics
Busy clinics deploy a reproducible, step-by-step OSD presurgical algorithm to manage diagnostic workflows without placing the entire burden on the surgeon. Technicians collect initial refractive measurements using topography, tomography, and keratometry. Inconsistent readings across these modalities frequently signal underlying ocular surface dysfunction.
Clinics use a dedicated OSD presurgical questionnaire featuring red-flag boxes to flag dry eye symptoms and other surface subtypes. Technicians score these forms so surgeons can immediately compare patient symptoms with refractive alignment. Technicians also perform point-of-care testing, including tear osmolarity and tear MMP-9 testing, alongside noncontact corneal esthesiometry.
Slit-lamp evaluations rely on the LLPP exam—standing for Look, Lift, Pull, Push—followed by corneal staining. This technician-led screening battery and physical examination workflow appear in the updated ASCRS field guide.
Delaying Surgery for Ocular Surface Disease Treatment
Surgeons assess collected data to determine if visually significant ocular surface disease is present and whether it aligns with the patient’s desired refractive strategy. When patients schedule surgery within one to two weeks and seek uncorrected visual acuity, clinicians delay the procedure if surface disease is detected.
Converting visually significant disease to a nonvisually significant state typically requires a six- to eight-week delay. Severe cases demand a longer pause. Clinicians treat every subtype simultaneously using multifaceted regimens that combine prescription drugs and procedural interventions.
Premium intraocular lens candidacy raises patient expectations for postoperative vision, demanding aggressive surface treatment before finalizing calculations. Even standard lenses require providers to diagnose and treat surface issues proactively. Failing to discuss preexisting disease beforehand often leads patients to view subsequent flare-ups as surgical complications.
Managing Dissatisfied Patients After 20/20 Vision Outcomes
Postoperative dissatisfaction often stems from fluctuating visual quality caused by underlying surface disease. When patients report inconsistent vision throughout the day, or state that lubricants temporarily clear their sight, the ocular surface serves as the primary culprit. Clinicians apply the same aggressive treatment regimens to eliminate these visual fluctuations. The ASCRS field guide outlines specific protocols for evaluating patients who achieve 20/20 visual acuity but remain dissatisfied, ruling out alternative causes while addressing surface dysfunction.
Keep reading